Publications by authors named "Katelee Barrett Mueller"

Objective: To examine changes in prevalence of overeating behaviors in a comparative effectiveness study of two pediatric weight management interventions.

Methods: Four-hundred and seven children, ages 6-12 years, with a BMI ≥ 85th percentile were enrolled in a comparative effectiveness trial of two pediatric weight management interventions. Prevalence of "sneaking, hiding or hoarding food", and 'eating in the absence of hunger' was evaluated at baseline and 12 months.

View Article and Find Full Text PDF

Rationale: Enhanced activation of the mineralocorticoid receptors (MRs) in cardiovascular tissues increases oxidative stress, maladaptive immune responses, and inflammation with associated functional vascular abnormalities. We previously demonstrated that consumption of a Western diet (WD) for 16 weeks results in aortic stiffening, and that these abnormalities were prevented by systemic MR blockade in female mice. However, the cell-specific role of endothelial cell MR (ECMR) in these maladaptive vascular effects has not been explored.

View Article and Find Full Text PDF

Overnutrition and insulin resistance are especially prominent risk factors for the development of cardiac diastolic dysfunction in females. We recently reported that consumption of a Western diet (WD) containing excess fat (46%), sucrose (17.5%), and high fructose corn syrup (17.

View Article and Find Full Text PDF

Arteriolar vasoreactivity tightly regulates tissue-specific blood flow and contributes to systemic blood pressure (BP) but becomes dysfunctional in the setting of cardiovascular disease. The mineralocorticoid receptor (MR) is known to regulate BP via the kidney and by vasoconstriction in smooth muscle cells. Although endothelial cells (EC) express MR, the contribution of EC-MR to BP and resistance vessel function remains unclear.

View Article and Find Full Text PDF
Article Synopsis
  • Aldosterone (aldo) is linked to cardiovascular disease by activating the mineralocorticoid receptor (MR), and blocking this receptor leads to improved heart health outcomes.
  • Estrogen (E2) can inhibit the harmful effects of aldo by activating the estrogen receptor (ER), which prevents MR from driving inflammatory responses that contribute to vascular issues, specifically by downregulating the gene ICAM-1.
  • The study finds that specific regions of the ER can directly interact with MR to inhibit its activity, suggesting a protective mechanism of estrogen in the vasculature against aldosterone-induced inflammation and related cardiovascular risks.
View Article and Find Full Text PDF